Aug
29
Biotech Boom Built Wall Street’s $3 Million Analyst
ByInvestment banks offer lucrative deals to attract and retain top-name biotechnology analysts
A biotech boom is fueling renewed interest in a group that has been out of favor: Wall Street analysts.
Investment banks Leerink Partners LLC, Cantor Fitzgerald & Co. and Jefferies Group LLC have lured top-name biotech analysts from large banks with guaranteed pay packages worth $3 million or more and contracts extending as long as three or four years, say people familiar with the matter…